YU220890A - Imunostimulatorni 6-aril-5,6-dihidroimidazo-/ 2,1-b/tiazol derivati - Google Patents

Imunostimulatorni 6-aril-5,6-dihidroimidazo-/ 2,1-b/tiazol derivati

Info

Publication number
YU220890A
YU220890A YU220890A YU220890A YU220890A YU 220890 A YU220890 A YU 220890A YU 220890 A YU220890 A YU 220890A YU 220890 A YU220890 A YU 220890A YU 220890 A YU220890 A YU 220890A
Authority
YU
Yugoslavia
Prior art keywords
aryl
6alkyl
immunostimulator
dihydroimidazo
derivatives
Prior art date
Application number
YU220890A
Other languages
English (en)
Other versions
YU47955B (sh
Inventor
A.H.M. Raeymaekers
L.F.C. Roevens
W.J.C.C. Laerhoven
J.P.F. Wauwe
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of YU220890A publication Critical patent/YU220890A/sh
Priority to HRP-2208/90A priority Critical patent/HRP930481A2/xx
Publication of YU47955B publication Critical patent/YU47955B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

IMUNOSTIMULATORNI 6-ARIL-5,6-DIHIDROIMIDAZO-/ 2,1-B/TIAZOL DERIVATI. Pronalazak se odnosi na nove 6-aril-5,6-dihroimidazolo/2,11-b/ triazol derivate opšte formule I: gde Ar je fenil supstituisan sa nekim od supsetituenata iz grupe koju čine, halo, hidroksi, C1-6alkoksi, merkapto, C1-6alkiltio, C1-6alkil, nitro, amino, mono i di (C1-6alkil)-amino, C1-6alkilkarbonilamino, aričkarbonilamino, C1-6alkilsulfonilamino, trifluorometil, ciano, aminokarbonil, piridinil, tienil, furanil, R1 i R2 svaki nezavisno su C1-20alkil, (C3-7cikloalkil)C1-6alkil, C3-7cikloalkil, aril ili (aril)C1-6alkil i jedan od R1 i R2 može biti vodonik ili zajedno mogu da grade C3-6alkandili radikal, kao i na postupak za dobivanje ovih derivata.
YU220890A 1989-11-24 1990-11-20 Imunostimulatorni 6-aril-5,6-dihidromidazo (2,1-b) tiazol derivati i postupak za njihovo dobijanje YU47955B (sh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HRP-2208/90A HRP930481A2 (en) 1989-11-24 1993-03-23 IMMUNOSIMULATING 6-ARYL-5,6-DIHYDROIMIDAZO/2,1-b/THIAZOLE DERIVATIVES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44084289A 1989-11-24 1989-11-24

Publications (2)

Publication Number Publication Date
YU220890A true YU220890A (sh) 1992-12-21
YU47955B YU47955B (sh) 1996-07-24

Family

ID=23750399

Family Applications (1)

Application Number Title Priority Date Filing Date
YU220890A YU47955B (sh) 1989-11-24 1990-11-20 Imunostimulatorni 6-aril-5,6-dihidromidazo (2,1-b) tiazol derivati i postupak za njihovo dobijanje

Country Status (25)

Country Link
EP (1) EP0430334B1 (sh)
JP (1) JPH03170487A (sh)
KR (1) KR910009714A (sh)
CN (1) CN1032754C (sh)
AT (1) ATE127795T1 (sh)
AU (1) AU630766B2 (sh)
BG (1) BG60587B1 (sh)
CA (1) CA2028756A1 (sh)
CZ (1) CZ281422B6 (sh)
DE (1) DE69022370T2 (sh)
FI (1) FI93459C (sh)
HU (1) HU206361B (sh)
IE (1) IE67656B1 (sh)
IL (1) IL96435A (sh)
MY (1) MY131024A (sh)
NO (1) NO300065B1 (sh)
NZ (1) NZ236026A (sh)
PL (1) PL165413B1 (sh)
PT (1) PT95978B (sh)
RO (1) RO108869B1 (sh)
RU (1) RU2051153C1 (sh)
YU (1) YU47955B (sh)
ZA (1) ZA909445B (sh)
ZM (1) ZM5390A1 (sh)
ZW (1) ZW17890A1 (sh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0524055A1 (fr) * 1991-07-19 1993-01-20 Synthelabo Dérivés d'imidazo[2,1-b]benzothiazole-3-acétamide, leur préparation et leur application en thérapeutique
US6165253A (en) * 1994-05-23 2000-12-26 New Jersey Institute Of Technology Apparatus for removal of volatile organic compounds from gaseous mixtures
NZ513487A (en) 1999-01-29 2003-02-28 Univ Illinois The use of a P53 inhibitor for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant
EP1797880A3 (en) * 1999-01-29 2010-04-28 Board Of Trustees Of The University Of Illinois P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant
CN102643818B (zh) 2004-09-28 2014-04-09 夸克制药公司 寡核糖核苷酸以及其用于治疗脱发、肾衰竭和其它疾病的方法
US7825099B2 (en) 2006-01-20 2010-11-02 Quark Pharmaceuticals, Inc. Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes
US7910566B2 (en) 2006-03-09 2011-03-22 Quark Pharmaceuticals Inc. Prevention and treatment of acute renal failure and other kidney diseases by inhibition of p53 by siRNA
EP2170403B1 (en) 2007-06-27 2014-04-16 Quark Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of pro-apoptotic genes
CN104557979A (zh) * 2013-10-23 2015-04-29 丹阳恒安化学科技研究所有限公司 盐酸左旋咪唑的制备方法
RU2763739C1 (ru) * 2021-06-28 2021-12-30 Федеральное государственное автономное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" (ПГНИУ) (Z)-9-ароил-8-гидрокси-6-(2-гидроксифенил)-2-(((Z)-2-оксоиндолин-3-илиден)гидразоно)-1-тиа-3,6-диазаспиро[4.4]нон-8-ен-4,7-дионы, обладающие противомикробной активностью
CN117203211A (zh) * 2021-11-29 2023-12-08 中国海洋大学 咪唑并噻唑衍生物及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU409983B2 (en) * 1965-07-19 1970-12-31 Imperial Chemical Industries Of Australia New Zealand Limited Process for the manufacture of thia zolidines and thiazolidines produced thereby
GB1444743A (en) * 1973-09-20 1976-08-04 Pfizer Ltd 7-substituted imidazo-1,1-b-thiazolium and 9-substituted thiazolo-3,2-a-benzimidazolium derivatives having hypogly caemic and/or growth promotant properties
US4340738A (en) * 1979-06-21 1982-07-20 Janssen Pharmaceutica, N.V. 2,3-Dihydro-imidazo[2,1-b]benzothiazoles

Also Published As

Publication number Publication date
ATE127795T1 (de) 1995-09-15
MY131024A (en) 2007-07-31
IL96435A (en) 1995-03-15
PT95978B (pt) 1998-01-30
PT95978A (pt) 1991-09-13
NO905086L (no) 1991-05-27
CZ281422B6 (cs) 1996-09-11
AU6680990A (en) 1991-05-30
NO905086D0 (no) 1990-11-23
BG93298A (bg) 1993-12-24
FI905788A0 (fi) 1990-11-23
PL287907A1 (en) 1992-04-21
CN1052117A (zh) 1991-06-12
NZ236026A (en) 1992-03-26
DE69022370T2 (de) 1996-03-14
ZW17890A1 (en) 1992-07-08
IE67656B1 (en) 1996-04-17
NO300065B1 (no) 1997-04-01
CN1032754C (zh) 1996-09-11
HUT59414A (en) 1992-05-28
IE904241A1 (en) 1991-06-05
BG60587B1 (bg) 1995-09-29
JPH03170487A (ja) 1991-07-24
CA2028756A1 (en) 1991-05-25
IL96435A0 (en) 1991-08-16
EP0430334B1 (en) 1995-09-13
ZA909445B (en) 1992-07-29
FI93459B (fi) 1994-12-30
FI93459C (fi) 1995-04-10
ZM5390A1 (en) 1992-06-30
HU206361B (en) 1992-10-28
KR910009714A (ko) 1991-06-28
RU2051153C1 (ru) 1995-12-27
CZ580390A3 (en) 1996-06-12
AU630766B2 (en) 1992-11-05
HU907633D0 (en) 1991-06-28
DE69022370D1 (de) 1995-10-19
EP0430334A1 (en) 1991-06-05
PL165413B1 (pl) 1994-12-30
YU47955B (sh) 1996-07-24
RO108869B1 (ro) 1994-09-30
FI905788A (fi) 1991-05-25

Similar Documents

Publication Publication Date Title
BG92804A (bg) 4-бензоилизоксазолови производни
HRP990167B1 (en) Sulphinic acid derivatives, method for producing them, and their use
PT97888A (pt) Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem
YU220890A (sh) Imunostimulatorni 6-aril-5,6-dihidroimidazo-/ 2,1-b/tiazol derivati
ATE69817T1 (de) Tetraoxodiazabicyclo-(3,3,1)-nonane.
SE8404712D0 (sv) Azole derivatives, process for their production compositions containing them and their use
ES8506629A1 (es) Un procedimiento para preparar derivados de piridina
ES8200094A1 (es) Procedimiento para la obtencion de alquilureas
PL335839A1 (en) Cycloalkylalkane carboxamides as well as their production and application
ES8604223A1 (es) Un procedimiento para preparar derivados de purina
AU7809281A (en) Novel guanidine derivatives
ES8705382A1 (es) Un procedimiento para la preparacion de nuevos derivados de carbaciclina.
GB866843A (en) Sulphonamidopyrimidines
ES8505994A1 (es) Un metodo para preparar 2(1h)-piridinonas
DE3067471D1 (en) 4-carbamoylimidazol-5-ol derivatives, their production and pharmaceutical compositions containing them
EP0169009A3 (en) Novel dihydropyridine derivatives and their production, formulation and use as pharmaceuticals
JPS57185270A (en) Novel cyclic sulfenamides, manufacture and use as drug
GB1042295A (en) Novel 4-sulfanilamido-pyrimidines and their salts and processes for the manufacture thereof
ES449777A1 (es) Un procedimiento para la preparacion de n-(5-tetrazolil)-pi-rimido (1, 2-a) quinolin-2-carboxamidas.
AU6916081A (en) Thiazole derivatives their preparation and pharmaceutical compositions containing them
ES471125A1 (es) Procedimiento para preparar derivados de 1-aminoindolina
IE41217B1 (en) Quinonoxime - aclhydrazone derivatives their preperation and their use as fungicides
AU545800B2 (en) New compounds
JPS574985A (en) Novel imidazolyl-indeno-thiophene compound, manufacture and pharmaceutical use
GB1039375A (en) Dibenzocycloheptene compounds